Skip to main content

Advertisement

Log in

Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa

  • Case report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The purpose of this paper was to describe a patient with pericentral retinitis pigmentosa (RP) and cystoid macular edema (CME) refractory to oral acetazolamide alone who was successfully treated with adjunctive pegaptanib sodium. A 33-year-old man presented with decreased vision and a best-corrected visual acuity (BCVA) in his left eye of 20/200 due to CME secondary to RP. Although he had been treated daily for 1 month with 500 mg of oral acetazolamide, the edema was unresponsive. When informed of the available treatment options, the patient requested adjunctive intravitreal pegaptanib sodium. One month after receiving an injection of pegaptanib sodium 0.3 mg and continued daily acetazolamide, the patient’s BCVA had improved to 20/40. At the 4-month follow-up visit, no recurrence of CME was found on fundus biomicroscopy, fundus-related perimetry, and optical coherence tomography. We conclude that intravitreal pegaptanib sodium combined with daily doses of acetazolamide appears to provide benefits in CME refractory to oral acetazolamide alone with regards to the improvement of visual acuity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sandberg MA, Gaudio AR, Berson EL (2005) Disease course of patients with pericentral retinitis pigmentosa. Am J Ophthalmol 140:100–106

    PubMed  Google Scholar 

  2. Noble KG, Carr RE (1978) Peripapillary pigmentary retinal degeneration. Am J Ophthalmol 86:65–75

    PubMed  CAS  Google Scholar 

  3. Hayasaka S, Fukuda K, Tsuchiya M, Mizuno K (1985) Pericentral pigmentary retinal degeneration. Jpn J Ophthalmol 29:161–169

    PubMed  CAS  Google Scholar 

  4. Yamaguchi K, Kin-Para Y, Tamai M (1991) Idiopathic central serous choroidopathy in a patient with pericentral pigmentary retinal degeneration. Ann Ophthalmol 23:251–253

    PubMed  CAS  Google Scholar 

  5. Fenkenhour CL, Choromokos E, Weinstein J, Shoch D (1977) Cystoid macular oedema in retinitis pigmentosa. Trans Am Acad Ophthalmol Otolaryngol 83:515–521

    Google Scholar 

  6. Fishman GA, Maggiano JM, Fishman M (1977) Foveal lesions seen in retinitis pigmentosa. Arch Ophthalmol 95:1993–1996

    PubMed  CAS  Google Scholar 

  7. Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106:1190–1195

    PubMed  CAS  Google Scholar 

  8. Saraiva VS, Sallum JM, Farah ME (2003) Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 34:398–400

    PubMed  Google Scholar 

  9. García-Arumi J, Martinez V, Sararols L, Corcostegui B (2003) Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology 110:1164–1169

    Article  PubMed  Google Scholar 

  10. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805–2816

    Article  PubMed  CAS  Google Scholar 

  11. Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109

    PubMed  CAS  Google Scholar 

  12. Melo GB, Farah ME, Aggio FB (2007) Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand 85:461–463

    Article  PubMed  Google Scholar 

  13. Nao-i N, Fukiyama J, Sawada A (1996) Retinitis pigmentosa with recurrent vitreous hemorrhage. Acta Ophthalmol Scand 74:509–512

    Article  PubMed  CAS  Google Scholar 

  14. Kadayifçilar S, Eldem B, Kiratli H (2000) Retinitis pigmentosa associated with peripheral sea fan neovascularization. Acta Ophthalmol Scand 78:593–595

    Article  PubMed  Google Scholar 

  15. Arden GB (2001) The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br J Ophthalmol 85:366–370

    Article  PubMed  CAS  Google Scholar 

  16. Lahdenranta J, Pasqualini R, Schlingemann RO, Hagedorn M, Stallcup WB, Bucana CD, Sidman RL, Arap W (2001) An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc Natl Acad Sci USA 98:10368–10373

    Article  PubMed  CAS  Google Scholar 

  17. Heckenlively JR, Jordan BL, Aptsiauri N (1999) Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127:565–573

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Querques.

Additional information

The authors have no proprietary interest in the materials used in this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Querques, G., Prascina, F., Iaculli, C. et al. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Int Ophthalmol 29, 103–107 (2009). https://doi.org/10.1007/s10792-007-9175-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-007-9175-1

Keywords

Navigation